ASCRS To Participate In and Co-Fund Study on Post-LASIK Quality of Life with U.S. Food and Drug Administration

CHICAGO - (Business Wire) The American Society of Cataract and Refractive Surgery (ASCRS) today announced that it will participate in a post-LASIK quality of life study with the Joint LASIK Study Task Force, which includes the U.S. Food and Drug Administration (FDA), the National Eye Institute (NEI), ASCRS and the American Academy of Ophthalmology. ASCRS also announced that the ASCRS Foundation has committed funds to support this effort.

The FDA reaffirms that LASIK is both safe and effective. The Joint LASIK Study Task Force now will examine LASIK’S impact on the quality of patients’ daily lives. Simply defined, quality of life refers to a patient’s ability to perform the activities of daily living, everything from driving, daily routine, family life, career and sports performance, to personal appearance, after LASIK. While the FDA reports that nearly all patients are satisfied with their procedure, the study will seek to qualify LASIK’s benefits and provide greater understanding of the very few patients whose expectations are not met with the procedure, with the goal of identifying ways to enhance patient care.

source: ASCRS.org